Brief: Bellicum Pharmaceuticals Inc Reports Quarterly Loss Per Share Of $0.68
06/11/2019 22:27
Nov 6 (Reuters) - Bellicum Pharmaceuticals Inc BLCM.O :
* BELLICUM PHARMACEUTICALS REPORTS THIRD QUARTER 2019
FINANCIAL
RESULTS AND PROVIDES OPERATIONAL UPDATE
* BELLICUM REPORTED CASH, RESTRICTED CASH AND INVESTMENTS
TOTALING
$106.9 MILLION AS OF SEPTEMBER 30, 2019
* QTRLY LOSS PER SHARE $0.68
* Q3 EARNINGS PER SHARE VIEW $-0.53 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNXc9dS55
Further company coverage: BLCM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bellicum Pharmaceuticals
See all newsBrief: Bellicum Pharmaceuticals- In Connection With Dissolution And Plan Of Dissolution, On February 23, Richard A. Fair Resigned As President And Co's CEO
Brief: Bellicum Pharmaceuticals Says Board Approved Liquidation And Dissolution Of Co In Connection With Approval Of Asset Purchase Agreement
Brief: Bellicum Pharmaceuticals Initiated A 12 Stock Split On Dec 8, 2022
Brief: Bellicum Reports Third Quarter 2022 Financial Results And Provides Operational Update
Bellicum Pharmaceuticals Inc expected to post a loss of 64 cents a share - Earnings Preview